Skip to main content
SpringerLink
Log in

Screening for Cancers of Other Sites: Lung, Stomach, Oral and Neuroblastoma

  • Chapter
Evaluation of Cancer Screening

Part of the book series: Focus on Cancer ((3292))

  • 63 Accesses

Abstract

Screening has been advocated as a means of control for various other cancer sites, four of which are reviewed here. Lung cancer, although theoretically preventable, is still the commonest cancer in the developed world and is rapidly increasing in developing countries. Studies of screening, however, have led to the conclusion that it is largely ineffective due to the rapid progression of potentially fatal disease.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Auerbach O, Hammond EC, Garfinkel L (1979) Changes in bronchial epithelium in relation to cigarette smoking, 1955–1960 vs 1970–1977. N Engl J Med 300:381–386.

    Article  PubMed  CAS  Google Scholar 

  2. Axell T (1987) Occurrence of leukoplakia and some other oral white lesions among 20 333 adult Swedish people. Community Dent Oral Epidemiol 15:46–51.

    Article  PubMed  CAS  Google Scholar 

  3. Bailar JC (1984) Screening for lung cancer — where are we now? Am Rev Respir Dis 130:541–542.

    PubMed  Google Scholar 

  4. Barker DJ, Coggon D, Holdsmond C, Wickham C (1990) Poor housing and high rates of stomach cancer in England and Wales. Br J Cancer 61:575–578.

    Article  PubMed  CAS  Google Scholar 

  5. Beckwith JB, Perrin EV (1963) In-situ neuroblastomas: a contribution to the natural history of neural crest tumours. Am J Pathol 43:1089–1104.

    PubMed  CAS  Google Scholar 

  6. Berlin NI, Buncher CR, Fontana RS, Frost JK, Melamed MR (1984) The National Cancer Institute Cooperative Early Lung Cancer Detection Program. Results of the initial screen (prevalence). Early lung cancer detection: introduction. Am Rev Respir Dis 130:545–549.

    PubMed  CAS  Google Scholar 

  7. Bernstein ML, Leclerc JM, Bunin G et al. (1992) A population-based study of neuroblastoma incidence, survival and mortality in North America. J Clin Oncol 10:323–329.

    PubMed  CAS  Google Scholar 

  8. Besscho F, Hashizuma K, Nakajo T, Kamoshita S (1991) Mass screening in Japan increased the detection of infants with neuroblastoma without a decrease in cases in older children. J Pediatr 119:237–241.

    Article  Google Scholar 

  9. Birrer MJ, Brown PH (1992) Application of molecular genetics to the early diagnosis and screening of lung cancer. Cancer Res (Suppl) 52:2658–2664.

    Google Scholar 

  10. Black RJ, Sharp L, Kendrick SW (1993) Trends in cancer survival in Scotland 1968–1990. ISD Publications, Edinburgh.

    Google Scholar 

  11. Blot WJ, McLaughlin JK, Wynn DM et al. (1988) Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res 48:3282–3287.

    PubMed  CAS  Google Scholar 

  12. Blot WJ (1992) Alcohol and cancer. Cancer Res 50(Suppl):2119–2123.

    Google Scholar 

  13. Boyle P, Macfarlane GJ, Maisonneuve P, Zheng T (1990) Epidemiology of mouth cancer in 1989: a review. J R Soc Med 83:724–730.

    PubMed  CAS  Google Scholar 

  14. Boyle P, Macfarlane GJ, Scully C (1993) Oral cancer: necessity for prevention strategies. Lancet 342:1129.

    Article  PubMed  CAS  Google Scholar 

  15. Brett GZ (1968) The value of lung cancer detection by six-monthly chest radiographs. Thorax 23:414–420.

    Article  PubMed  CAS  Google Scholar 

  16. Brodeur GM, Hayes FA, Green AA et al. (1987) Consistent N-myc copy number in simultaneous or consecutive neuroblastoma samples from sixty individual patients. Cancer Res 47:4248–4253.

    PubMed  CAS  Google Scholar 

  17. Brodeur GM, Pritchard J, Berthold F et al. (1993) Revisions of the International Criteria for Neuroblastoma Diagnosis, Staging and Response to Treatment. J Clin Oncol 11:1466–1477.

    PubMed  CAS  Google Scholar 

  18. Cancer Research Campaign (1990) Fact Sheet 14: Oral Cancer

    Google Scholar 

  19. Cancer Research Campaign (1992) Fact Sheet 11: Lung Cancer.

    Google Scholar 

  20. Chamberlain J (1994) Screening for neuroblastoma. A review of the evidence. J Med Screening 1:169–175.

    CAS  Google Scholar 

  21. Coffin F (1964) Cancer and the dental surgeon. Br Dental J 116:191–202.

    Google Scholar 

  22. Coldman AJ, Fryer CH, Elwood JM, Sonley MJ (1980) Neuroblastoma: influence of age at diagnosis, stage, tumour site and sex on prognosis. Cancer 46:1896–1901.

    Article  PubMed  CAS  Google Scholar 

  23. Doll R, Peto R (1976) Mortality in relation to smoking: 20 years’ observation on British male doctors. Br Med J iv:1525–1526.

    Article  Google Scholar 

  24. Draper GJ, Birch JM, Bithell JF et al. (1982) Childhood cancer in Britain. Studies on medical and population subjects, No. 37. HMSO, London.

    Google Scholar 

  25. Ebeling K, Nischan P (1987) Screening for lung cancer — results from a case-control study. Int J Cancer 40:141–144.

    Article  PubMed  CAS  Google Scholar 

  26. Eddy DM (1989) Screening for lung cancer. Ann Intern Med 111:232–237.

    PubMed  CAS  Google Scholar 

  27. Eurogast Study Group (1993) An international association between Helicobacter pylori infection and gastric cancer. Lancet 341:1359–1362.

    Article  Google Scholar 

  28. Flehinger BJ, Melamed Mr, Zaman MB et al. (1984) Screening for early detection of lung cancer in New York. In: Prorok PC, Miller AB (eds) Screening for cancer. I. General principles on evaluation of screening for cancer and screening for lung, bladder and oral cancer. UICC Technical Report Series, 78, Geneva, pp 123–135.

    Google Scholar 

  29. Fontana RS, Sanderson DR, Woolner LB, Taylor WF, Miller WE, Muhm JR (1986) Lung cancer screening: The Mayo Program. J Occup Med 28:746–750.

    Article  PubMed  CAS  Google Scholar 

  30. Fukao A, Hisamichi S, Sugawara N (1987) A case-control study on evaluating the effect of mass screening on decreasing advanced stomach cancer. J Jpn Soc Gastroenterol Mass Surv 75:112–116.

    Google Scholar 

  31. Goodwin CS (1993) Gastric cancer and Helicobacter pylori: the whispering killer? Lancet 342:507–508.

    Article  PubMed  CAS  Google Scholar 

  32. Gupta PC, Mehta FS, Daftary DK et al. (1980) Incidence rates of oral cancers and natural history of oral precancerous lesions in a 10 year follow up study of Indian villages. Community Dental Oral Epidemiol 8:287–333.

    Article  Google Scholar 

  33. Hakama M, Pukkala E (1988) Evaluation of an immunological screening for stomach cancer. In: Chamberlain J, Miller AB (eds) Screening for gastrointestinal cancer. International Union Against Cancer. Hans Huber, Toronto, pp 71–75.

    Google Scholar 

  34. Hakama M, Stenman U-H, Knekt P et al. (1994) Tumour markers and screening for gastrointestinal cancer: a follow up study in Finland. J Med Screening 1:60–64.

    CAS  Google Scholar 

  35. Hallissey MT, Allum WH, Jewkes AJ, Ellis DJ, Fielding JWL (1990) Early detection of gastric cancer. Br Med J 301:513–515.

    Article  CAS  Google Scholar 

  36. Hanawa Y, Sawada T, Tsunoda A (1990) Decrease in childhood neuroblastoma death in Japan. Med Pediatr Oncol 18:472–475.

    Article  PubMed  CAS  Google Scholar 

  37. Hayashi Y, Kanda N, Inaba T et al. (1989) Cytogenetic findings and prognosis in neuroblastoma with emphasis on marker chromosome 1. Cancer 63:126–132.

    Article  PubMed  CAS  Google Scholar 

  38. Hisamichi A, Fukao A, Sugawara N et al. (1991) Evaluation of mass screening programme for stomach cancer in Japan. In: Miller AB, Chamberlain J, Day NE, Hakama M, Prorok PC (eds) Cancer Screening. International Union Against Cancer. Cambridge University Press, Cambridge, pp 357–370.

    Google Scholar 

  39. International Agency for Research on Cancer (1985) Tobacco habits other than smoking, betel quid and areca-nut chewing; and some related nitrosamines. IARC Monographs on the evaluation of carcinogenic risk of chemicals to humans. IARC 37, Lyon.

    Google Scholar 

  40. International Agency for Research on Cancer (1989) Monograph 42: alcoholic beverages. IARC, Lyon.

    Google Scholar 

  41. Ishimoto K, Kiyokawa N, Fujita H et al. (1990) Problems of mass screening for neuroblastoma = analysis of false negative cases. J Pediatr Surg 5:398–401.

    Article  Google Scholar 

  42. Johnson NW, Ranasinghe AW, Warnakulasuriya KAAS (1993) Potentially malignant lesions and conditions of the mouth and oropharynx: natural history — cellular and molecular markers of risk. Eur J Cancer 2(2):31–51.

    Google Scholar 

  43. Kaneko Y, Kanda N, Maseki N et al. (1990) Current urinary mass screening for catecholamine metabolities at 6 months of age may be detecting only a small portion of high-risk neuroblastomas: a chromosome and N-myc amplification study. J Clin Oncol 8:2005–2013.

    PubMed  CAS  Google Scholar 

  44. Knudson AG, Meadow AT (1980) Regression of neuroblastoma IVS: a genetic hypothesis. N Engl J Med 302:1254–1256.

    Article  PubMed  Google Scholar 

  45. Kubik A, Parkin DM, Khlat M, Erban J, Polak J, Adamec M (1990) Lack of benefit from semi-annual screening for cancer of the lung: follow-up report of a randomized controlled trial on a population of high-risk males in Czechoslovakia. Int J Cancer 45:26–33.

    Article  PubMed  CAS  Google Scholar 

  46. Lamay P-J (1993) Management options in potentially malignant and malignant oral epithelial lesions. Community Dental Health 10(1):53–62.

    Google Scholar 

  47. Lancet (1986) Oral snuff: a preventable carcinogenic hazard. Lancet i: 198–201.

    Google Scholar 

  48. McLoughlin JK, Gridley G, Block G et al. (1988) Dietary factors in oral and pharyngeal cancer. J Natl Cancer Inst 80:1237–1243.

    Article  Google Scholar 

  49. Malaowalla AM, Silverman S, Mani NJ, Bilimoria KF, Smith LW (1976) Oral cancer in 57518 industrial workers in Gujarat, India. Cancer 37:1882–1886.

    Article  Google Scholar 

  50. Matsumara M, Tsunoda A, Nishi T, Nishihira H, Sasaki Y (1991) Spontaneous regression of neuroblastoma detected by mass screening. Lancet 338:447–448.

    Article  Google Scholar 

  51. Melamed MR, Flehinger BJ, Zaman MB et al. (1984) Screening for lung cancer. Results of the Memorial Sloan-Kettering study in New York. Chest 86:44–53.

    CAS  Google Scholar 

  52. Miller AB (1989) Vitamins, minerals and other dietary factors. In: Miller AB (ed) Diet and the aetiology of cancer. Springer-Verlag, Berlin, pp 39–54.

    Google Scholar 

  53. Mincer HH, Coleman SA, Hopkins KP (1972) Observations on the clinical characteristics of oral lesions showing histologic epithelial dysplasia. Oral Surg Oral Med Oral Pathol 33:389–399.

    Article  PubMed  CAS  Google Scholar 

  54. Morson BC (1955) Intestinal metaplasia of gastric mucosa. Br J Cancer 9:365–376.

    Article  PubMed  CAS  Google Scholar 

  55. Naito H, Sasaki M, Yamashiro K et al. (1990) Improvement in prognosis of neuroblastoma through mass population screening. J Pediatr Surg 25:245–248.

    Article  PubMed  CAS  Google Scholar 

  56. Nash FA, Morgan JM, Tomkins JG (1968) South London lung cancer study. Br Med J 2:715–721.

    Article  PubMed  CAS  Google Scholar 

  57. Nishi M, Miyaké H, Takeda T et al. (1987) Effects of the mass screening of neuroblastoma in Sapporo City. Cancer 60:433–435.

    Article  PubMed  CAS  Google Scholar 

  58. Nishi M, Miyake H, Takeda T, Takasugi N, Hanai J, Kawai T (1991) Mass screening for neuroblastoma and estimation of costs. Acta Paediatr Scand 80:812–817.

    Article  PubMed  CAS  Google Scholar 

  59. Office of Population Censuses and Surveys (1993) Cancer statistics. Registrations. Series MB1 no. 20. HMSO, London.

    Google Scholar 

  60. Office of Population Censuses and Surveys (1993) Mortality statistics. Cause. Series DH2 no. 19. HMSO, London.

    Google Scholar 

  61. Oshima A, Hirata N, Ubukata T, Umeda K, Fujimoto I (1986) Evaluation of a mass screening program for stomach cancer with a case-control study design. Int J Cancer 38:829–833.

    Article  PubMed  CAS  Google Scholar 

  62. Parker L, Craft AW, Dale G et al. (1992) Screening for neuroblastoma in the North of England. Br Med J 305:1260–1263.

    Article  CAS  Google Scholar 

  63. Parkin DM, Laara E, Muir CS (1988) Estimates of the worldwide frequency of sixteen major cancers in 1980. Int J Cancer 41:184–197.

    Article  PubMed  CAS  Google Scholar 

  64. Parkin DM, Stiller CA, Draper GJ et al. (1988) International incidence of childhood cancer. IARC, Scientific Publications, No. 87, Lyon, 1988.

    Google Scholar 

  65. Peto R (1994) Smoking and death: the past 40 years and the next 40. Br Med J 309:937–939.

    Article  CAS  Google Scholar 

  66. Pindborg JJ (1980) Oral cancer and precancer. John Wright and Sons Ltd, Bristol.

    Google Scholar 

  67. Pindborg JJ, Daftary DK, Gupta P et al. (1991) Public health aspects of oral cancer: implications for cancer prevention in the community. In: Johnson NW (ed) Risk markers for oral cancer: detection of patients and lesions at risk, Vol 2. Cambridge University Press, Cambridge, pp 380–388.

    Google Scholar 

  68. Pisani P, Oliver WE, Parkin DM, Alvarez N (1994) Case-control study of gastric cancer screening in Venezuela. Br J Cancer 69:1102–1105.

    Article  PubMed  CAS  Google Scholar 

  69. Platz H, Fries R, Hudec M (1986) Prognoses of oral cavity carcinomas. Carl Hanser Verlag, Munich, pp 187.

    Google Scholar 

  70. Pogrel MA (1974) The dentist and oral cancer in the north east of Scotland. Br Dental J 137:15–20.

    Article  CAS  Google Scholar 

  71. Prorok PC, Byar DP, Smart CR, Baker SG, Connor RJ (1991) Evaluation of screening for prostate, lung and colorectal cancers: the PLC trial. In: Miller AB, Chamberlain J, Day NE, Hakama M, Prorok PC (eds) Cancer screening. Cambridge University Press, Cambridge, pp 300–321.

    Google Scholar 

  72. Saccomano G, Archer VE, Auerbach O, Saunders RP, Brennan LM (1974) Development of carcinoma of the lung as reflected in exfoliated cells. Cancer 33:256–270.

    Article  Google Scholar 

  73. Sankila R, Hakama M (1993) Survival trends for neuroblastoma in Finland: negative reflections on screening. Eur J Cancer 29:122–123.

    Article  Google Scholar 

  74. Sawada T, Kidowaki T, Sakamoto I et al. (1984) Neuroblastoma: mass screening for early detection and its prognosis. Cancer 53:2731–2735.

    Article  PubMed  CAS  Google Scholar 

  75. Sawada T, Kawakatu H, Sugimoto T (1987) Screening for neuroblastoma. Lancet ii:1204.

    Article  Google Scholar 

  76. Sawada T, Matsumara T, Matsuda Y, Kawakatsu H (1991) Neuroblastoma studies in Japan. In: Miller AB, Chamberlain J, Day NE, Hakama M, Prorok PC (eds) Cancer screening. Cambridge University Press, Cambridge, pp 325–336.

    Google Scholar 

  77. Schnetler JFC (1992) Oral cancer diagnosis and delays in referral. Br J Oral Maxillo-facialSurg 30:210–213.

    Article  CAS  Google Scholar 

  78. Scully C (1993) Clinical diagnostic methods for the detection of premalignant and early malignant oral lesions. Community Dental Health 10(1):43–52.

    PubMed  Google Scholar 

  79. Shafer WG (1975) Initial mismanagement and delay in diagnosis of oral cancers. J Am Dent Assoc 90:1262–1264.

    PubMed  CAS  Google Scholar 

  80. Sobue T, Suzuki T, Naruke T and The Japanese Lung Cancer Screening Research Group (1992) A case-control study for evaluating lung cancer screening in Japan. Int J Cancer 50:230–237.

    Article  PubMed  CAS  Google Scholar 

  81. Souhami R (1992) Lung cancer. Br Med J 304:1298–1301.

    Article  CAS  Google Scholar 

  82. Speight PM, Morgan PR (1993) The natural history and pathology of oral cancer and precancer. Community Dental Health 10(1):31–41.

    PubMed  Google Scholar 

  83. Stiller CA, Bunch KJ (1990) Trends in survival for childhood cancer diagnosed 1971-85. Br J Cancer 62:806–816.

    Article  PubMed  CAS  Google Scholar 

  84. Stiller CA (1993) Trends in neuroblastoma in Great Britain: incidence and mortality, 1971–1990. Eur J Cancer 29A:1008–1012.

    Article  PubMed  CAS  Google Scholar 

  85. Sue-Ling HM, Johnston D, Martin IC et al. (1993) Gastric cancer: a curable disease in Britain. Br Med J 307:591–596.

    Article  CAS  Google Scholar 

  86. Tockman MS, Frost JK, Stitik FP et al. (1985) Screening and detection of lung cancer. In: Aisner J (ed) Lung cancer. Churchill Livingstone, New York, pp 25–29.

    Google Scholar 

  87. Todd J, Lader D (1991) Adult dental health, United Kingdom 1988. HMSO, London.

    Google Scholar 

  88. Tsukuma T, Mishima T, Oshima A (1983) Prospective study of “early” gastric cancer. Int J Cancer 31:421–426.

    Article  PubMed  CAS  Google Scholar 

  89. Tuchman M, Lemieux B, Auray-Blais C et al. (1990) Screening for neuroblastoma at three weeks of age: methods and preliminary results from the Quebec neuroblastoma screening project. Pediatrics 86:765–773.

    PubMed  CAS  Google Scholar 

  90. Tuchman M, Ramnaraine ML, Woods WG et al. (1987) Three years of experience with random urinary homovanillic and vanillylmandelic acid levels in the diagnosis of neuroblastoma. Pediatrics 79:203–205.

    PubMed  CAS  Google Scholar 

  91. Walter SD, Kubik A, Parkin DM, Reissigova J, Adamec M, Khlat M (1992) The natural history of lung cancer estimated from the results of a randomized trial of screening. Cancer Causes and Control 3:115–123.

    Article  PubMed  CAS  Google Scholar 

  92. Wang B, Yanagawa H, Sakata K (1994) Gastric cancer screening programme in Japan: how to improve its implementation in the community. J Epidemiol Community Health 48:182–187.

    Article  PubMed  CAS  Google Scholar 

  93. Warnakulasuriya S, Ekanayake A, Stjernsward J, Pindborg JJ, Sivayoham S (1988) Compliance following referral in the early detection of oral cancer and precancer in Sri Lanka. Community Dent Oral Epidemiol 16:326–329.

    Article  PubMed  CAS  Google Scholar 

  94. Warnakulasuriya S, Pindborg JJ (1990) Reliability of oral precancer screening by primary health care workers in Sri Lanka. Comm Dental Hlth 7:73–79.

    CAS  Google Scholar 

  95. Weiss W (1984) Implications of tumor growth rate for the natural history of lung cancer. J Occup Med 26:345–352

    Article  PubMed  CAS  Google Scholar 

  96. Woods WG, Lemieux B, Tuchman M (1992) Neuroblastoma represents distinct clinical-biological entities: a review and perspective from the Quebec neuroblastoma screening project. Pediatrics 89:114–118.

    PubMed  CAS  Google Scholar 

  97. World Health Organization (1978) Definitions of leukoplakia and related lesions: an aid to studies on oral precancer. Oral Surg Oral Med Oral Pathol 46:518–539.

    Article  Google Scholar 

Download references

Authors
  1. Jocelyn Chamberlain
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Cancer Screening Evaluation Unit, Section of Epidemiology, Institute of Cancer Research, Block D, Cotswold Road, Sutton, Surrey, SM2 5NG, UK

    Jocelyn Chamberlain  & Sue Moss  & 

Rights and permissions

Reprints and permissions

Copyright information

© 1996 Springer-Verlag London Limited

About this chapter

Cite this chapter

Chamberlain, J. (1996). Screening for Cancers of Other Sites: Lung, Stomach, Oral and Neuroblastoma. In: Chamberlain, J., Moss, S. (eds) Evaluation of Cancer Screening. Focus on Cancer. Springer, London. https://doi.org/10.1007/978-1-4471-3044-4_8

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-3044-4_8

  • Publisher Name: Springer, London

  • Print ISBN: 978-3-540-19957-1

  • Online ISBN: 978-1-4471-3044-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation